Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
OPERATING ACTIVITIES:
Net loss	$ (106,913)	$ (54,045)
Adjustments to reconcile net loss to net cash provided by operating activities:
Share-based compensation expense	26,158	27,011
Depreciation and amortization expense, including amortization of deferred financing costs	163,190	156,841
Deferred rent	(14,140)	(20,594)
(Income) loss from unconsolidated real estate ventures, net	(4)	1,320
Amortization of market lease intangibles, net	175	(767)
Amortization of lease incentives	4,197	1,812
(Gain) loss on the extinguishment of debt	(43)	450
Impairment loss	18,236	59,307
(Gain) loss on the sale of real estate, net	5,066	(41,606)
Loss (income) on operating lease and other receivables	2,053	(67)
Income from investments, net	(3,278)	(1,163)
Return on capital from unconsolidated real estate ventures	1,680	12,633
Other non-cash items	4,626	8,586
Changes in operating assets and liabilities:
Tenant and other receivables	11,466	12,223
Other assets, net	(13,337)	(22,305)
Accounts payable and accrued expenses	(9,446)	(18,129)
Other liabilities, net	(2,496)	(6,614)
Net cash provided by operating activities	87,190	114,893
INVESTING ACTIVITIES:
Development costs, construction in progress and real estate additions	(172,051)	(241,336)
Acquisition of real estate		(19,551)
Proceeds from the sale of real estate	97,010	162,092
Proceeds from derivative financial instruments	5,073	465
Payments on derivative financial instruments	(6,468)	(9,830)
Distributions of capital from unconsolidated real estate ventures and other investments	163,880	9,264
Investments in unconsolidated real estate ventures and other investments	(5,027)	(24,344)
Net cash provided by (used in) investing activities	82,417	(123,240)
FINANCING ACTIVITIES:
Borrowings under mortgage loans	112,612	287,582
Borrowings under revolving credit facility	223,000	247,000
Borrowings under term loans		170,000
Repayments of mortgage loans	(85,662)	(280,135)
Repayments of revolving credit facility	(195,000)	(155,000)
Proceeds from derivative financial instruments		9,600
Payments on derivative financial instruments	(4,422)	(465)
Debt issuance and modification costs	(359)	(17,579)
Acquisition/redemption of noncontrolling interests	(26,569)	(647)
Proceeds from common shares issued pursuant to ESPP	792	665
Common shares repurchased	(168,371)	(273,851)
Dividends paid to common shareholders	(47,186)	(72,483)
Distributions to redeemable noncontrolling interests	(8,714)	(11,619)
Distributions to noncontrolling interests	(25)	(15)
Net cash used in financing activities	(199,904)	(96,947)
Net decrease in cash and cash equivalents, and restricted cash	(30,297)	(105,294)
Cash and cash equivalents, and restricted cash, beginning of period	200,441	274,073
Cash and cash equivalents, and restricted cash, end of period	170,144	168,779
SUPPLEMENTAL DISCLOSURE OF CASH FLOW AND NON-CASH INFORMATION:
Cash paid for interest (net of capitalized interest of $8,477 and $11,013 in 2024 and 2023)	84,195	65,416
Accrued capital expenditures included in accounts payable and accrued expenses	46,182	80,946
Write-off of fully depreciated assets	28,617	3,489
Redemption of OP Units for common shares	13,769	33,110
Recognition (derecognition) of operating lease right-of-use asset	(13,724)	61,443
Recognition (derecognition) of liabilities related to operating lease right-of-use asset	(13,724)	61,443
Cash paid for amounts included in the measurement of lease liabilities for operating leases	$ 7,980	$ 3,567